Research Article| Volume 14, ISSUE 3, P107-114, May 2005

Download started.


Intravascular Cooling in the Treatment of Stroke (ICTuS): Early Clinical Experience

      We sought to evaluate the safety and feasibility of mild therapeutic hypothermia using an endovascular temperature management system in awake acute ischemic stroke patients. The Intravascular Cooling in the Treatment of Stroke (ICTuS) study was an uncontrolled, multicenter development and feasibility study of conscious patients (n = 18) presenting within 12 hours of onset of an acute ischemic stroke at 5 clinical sites in the United States. Enrolled patients were to undergo core temperature management using an endovascular cooling system to induce and maintain mild, therapeutic hypothermia (target temperature of 33.0°C) for a period of either 12 or 24 hours, followed by controlled rewarming to 36.5°C over the subsequent 12-hour period. Nine patients underwent 12 hours of cooling followed by 12 hours of controlled rewarming, and 6 patients underwent 24 hours of cooling followed by 12 hours of controlled rewarming. Three patients underwent <1.5 hours of hypothermia due to clinical or technical issues. We also developed an antishivering regimen using buspirone and meperidine administered prophylactically to suppress shivering. The endovascular cooling catheter was well tolerated, with acceptable adverse event rates. Increasing the duration of hypothermia administration from 12 hours to 24 hours did not appear to increase the incidence or severity of adverse effects. Endovascular cooling with a proactive antishivering regimen can be accomplished in awake stroke patients. Further studies are needed to establish the safety and efficacy of this approach.

      Key words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Stroke and Cerebrovascular Diseases
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Bernard S.A.
        • Buist M.D.
        • Jones B.M.
        • et al.
        Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia.
        New Engl J Med. 2002; 346: 557-563
        • The Hypothermia After Cardiac Arrest Study Group
        Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest.
        New Engl J Med. 2002; 346: 549-556
        • Kammersgaard L.
        • Rasmussen B.H.
        • Jorgensen H.S.
        • et al.
        Feasibility and safety of inducing modest hypothermia in awake patients with acute stroke through surface cooling.
        Stroke. 2000; 31: 2251-2256
        • Krieger D.
        • De Georgia M.
        • Abou-Chebl A.
        • et al.
        Cooling for acute ischemic brain damage (COOL AID).
        Stroke. 2001; 32: 1847-1854
        • Schwab S.
        • Schwarz S.
        • Spranger M.
        • et al.
        Moderate hypothermia in the treatment of patients with severe middle cerebral artery infarction.
        Stroke. 1998; 29: 2461-2466
        • Steiner T.
        • Freide T.
        • Aschoff A.
        • et al.
        Effect and feasibility of controlled rewarming after moderate hypothermia in stroke patients with malignant infarction of the middle cerebral artery.
        Stroke. 2001; 32: 2833-2835
        • Zwefler R.M.
        • Voorhees M.E.
        • Mahmood M.A.
        • et al.
        Induction and maintenance of mild hypothermia by surface cooling in nonintubated subjects.
        J Stroke Cerebrovasc Dis. 2003; 12: 237-243
        • Schwab S.
        • Georgiadis D.
        • Berrouschot J.
        • et al.
        Feasibility and safety of moderate hypothermia after massive hemispheric infarction.
        Stroke. 2001; 32: 2033-2035
        • De Georgia M.A.
        • Krieger D.W.
        • Abou-Chebl A.
        • et al.
        Cooling for acute ischemic brain damage (COOL AID).
        Neurology. 2004; 63: 312-317
        • Lyden P.
        • Brott T.
        • Tilley B.
        • et al.
        • NINDS TPA Stroke Study Group
        Improved reliability of the NIH stroke scale using video training.
        Stroke. 1994; 25: 2220-2226
        • Mahoney F.T.
        • Barthel D.W.
        Functional evaluation.
        Md State Med J. 1965; 14: 61-65
        • Rankin J.
        Cerebral vascular accidents in patients over the age of 60.
        Scott Med J. 1957; 2: 200-215
        • Mokhtarani M.
        • Mahgoub A.N.
        • Morioka M.
        • et al.
        Buspirone and mederidine synergistically reduce the shivering threshold.
        Anesth Anal. 2001; 93: 1233-1239
        • NINDS rt-PA Stroke Study Group
        Tissue plasminogen activator for acute ischemic stroke.
        N Engl J Med. 1995; 333: 1581-1587
        • Mian N.Z.
        • Bayly R.
        • Schreck D.M.
        • et al.
        Incidence of deep venous thrombosis associated with femoral venous catheterization.
        Acad Emerg Med. 1997; 4: 1118-1121
        • Johnston K.C.
        • Li J.Y.
        • Lyden P.D.
        • et al.
        Medical and neurological complications of ischemic stroke: Experience from the RANTTAS trial. RANTTAS Investigators.
        Stroke. 1998; 29: 447-453
        • Alfonsi P.
        • Sessler D.I.
        • Du Manoir B.
        The effects of meperidine and sufentanil on the shivering threshold in postoperative patients.
        Anesthesiology. 1998; 89: 43-48